Abiopharma

News list

Lisle Shawn G 🟡 adjusted position in 339 shares (1 derivative) of STEPAN CO (SCL) at $62.34 Transaction Date: Aug 26, 2026 | Filing ID: 000119

Full text

News bot Aug. 28, 2026, 5:08 p.m.
🔍 Lisle Shawn G (Executive)

Company: STEPAN CO (SCL)

Report Date: 2026-08-26
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,154
- Total shares sold: 1,493
Detailed Transactions and Holdings:
- Acquired 1,154 shares of Common Stock at $62.345 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,179.54 | transaction_form_type: 4 | Footnotes: F1
- Sold 339 shares of Common Stock at $62.345 per share (Direct)
  Date: 2026-08-26 | Code: F | equity_swap_involved: 0 | shares_owned_after: 840.54 | transaction_form_type: 4 | Footnotes: F2
- Sold 1,154 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2028-08-26 | Exercise: 2026-08-26 | equity_swap_involved: 0 | shares_owned_after: 2,308.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award.
- F2: Withholding of shares to satisfy tax liability on the vesting of RSUs.
- F3: Each RSU represents a contingent right to receive one share of Stepan Company common stock.
- F4: Vest ratably over three years beginning on the date shown.